Multicenter trial of fluoxetine as an adjunct to behavioral smoking cessation treatment

Journal of Consulting and Clinical Psychology

Volumn 70, Issue 4, 2002, Pages 887-896

  Niaura, Raymond ^a,h   Spring, Bonnie ^b   Borrelli, Belinda ^a   Hedeker, Donald ^b   Goldstein, Michael G ^a   Keuthen, Nancy ^c   Depue, Judy ^a   Kristeller, Jean ^d   Ockene, Judy ^e   Prochazka, Allan ^f   Chiles, John A ^g   Abrams, David B ^a  

^a MIRIAM HOSPITAL   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d INDIANA STATE UNIVERSITY   (United States)

^e UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^f VETERANS AFFAIRS MEDICAL CENTER   (United States)

^g UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^h BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOXETINE;

ADDICTION; ADULT; ARTICLE; BEHAVIOR THERAPY; CIGARETTE SMOKING; CLINICAL TRIAL; COGNITIVE THERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; EVALUATION; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MODEL; MULTICENTER STUDY; OUTCOMES RESEARCH; PSYCHOTHERAPY; RANDOMIZED CONTROLLED TRIAL; SELF REPORT; SMOKING CESSATION; SMOKING HABIT;

EID: 0036330654     PISSN: 0022006X     EISSN: None     Source Type: Journal    
DOI: 10.1037/0022-006X.70.4.887     Document Type: Article

References (50)

1. Depression and the dynamics of smoking. A national perspective
2. The effects of fluoxetine combined with nicotine inhalers in smoking cessation - A randomized trial
3. Tryptophan and high carbohydrate diets as adjuncts to smoking cessation therapy
4. Cigarette smoking among adults: United States, 1993
5. State-specific prevalence of current cigarette smoking among adults: United States, 1998
6. Fluoxetine versus placebo to decrease the smoking of depressed alcoholic patients
7. Double-blind fluoxetine in depressed alcoholic smokers
8. Depression and depressive symptoms in smoking cessation
9. Optimum cutoff points for biochemical validation of smoking status
10. Terminal 5-HT autoreceptor desensitization in the orbitofrontal cortex is produced exclusively by drugs effective in obsessive compulsive disorder
11. Hamilton Depression Rating Scale: Extracted from regular and change versions of the Schedule for Affective Disorders and Schizophrenia
12. Measuring degree of physical dependence to tobacco smoking with reference to individualization of treatment
13. Cigarette smoking: Implications for psychiatric illness
14. Heavy smokers, smoking cessation, and clonidine: Results of a double-blind, randomized trial
15. Pharmacotherapy of bulimia nervosa with fluoxetine: Assessment of clinically significant attitudinal change
16. Fluoxetine: A randomized clinical trial in the treatment of obesity
17. Statistical analysis of randomized trials in tobacco treatment: Longitudinal designs with dichotomous outcomes
18. Nortriptyline and cognitive-behavioral therapy in the treatment of cigarette smoking
19. A rating scale for depression
20. Efficacy of bupropion for smoking cessation in smokers with a former history of major depression or alcoholism
21. MIXOR: A computer program for mixed-effects ordinal regression analysis
22. Application of random-effects pattern-mixture models for missing data in longitudinal studies
23. The natural history of smoking: A pattern-mixture random-effects regression model
24. Antidepressant pharmacotherapy helps some smokers more than others
25. Tobacco withdrawal in self-quitters
26. A comparison of sustained-release bupropion and placebo for smoking cessation
27. Low serotonin and dopamine metabolite concentrations in cerebrospinal fluid from bulimic patients with frequent binge episodes
28. Smoking and major depression: A causal analysis
29. Nicotine patch and paroxetine for smoking cessation
30. Missing data in longitudinal studies
31. Use of fluoxetine, a selective serotonin-uptake inhibitor, in the treatment of obesity: A dose-response study
32. Modeling the drop-out mechanism in repeated measures studies
33. Fluoxetine differentially alters alcohol intake and other consummatory behaviors in problem drinkers
34. Fluoxetine, symptoms of depression, and smoking cessation
35. Efficacy of drug treatment in obsessive-compulsive disorder: A meta-analytic review
36. A randomized trial of nortriptyline for smoking cessation
37. Influences of negative affect on smoking cessation treatment outcome: A pilot study
38. Overview of research on smoking cessation
39. Systematic changes in cerebral glucose metabolic rate after successful behavior modification treatment of obsessive compulsive disorder
40. Do serotonin uptake inhibitors decrease smoking? Observations in a group of heavy drinkers
41. Weight gain related to tobacco withdrawal
42. Cigarette smoking and body weight: Strategies to minimize weight gain after smoking cessation
43. Weight gain and withdrawal symptoms after smoking cessation: A preventive intervention using d-Fenfluramine
44. Efficacies of dexfenfluramine and fluoxetine in preventing weight gain after smoking cessation
45. Severity of withdrawal symptoms as a predictor of outcome of an attempt to quit smoking
46. Pharmacotherapy of bulimia nervosa - Experience with fluoxetine
47. Measures of affect and nicotine dependence predict differential response to smoking cessation treatments